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abstract
 
Activation of the cardiac ryanodine receptor (RyR2) by Ca
 
2
 
 
 
 is an essential step in excitation-contrac-
tion coupling in heart muscle. However, little is known about the molecular basis of activation of RyR2 by Ca
 
2
 
 
 
. In
this study, we investigated the role in Ca
 
2
 
 
 
 sensing of the conserved glutamate 3987 located in the predicted trans-
membrane segment M2 of the mouse RyR2. Single point mutation of this conserved glutamate to alanine
(E3987A) reduced markedly the sensitivity of the channel to activation by Ca
 
2
 
 
 
, as measured by using single-chan-
nel recordings in planar lipid bilayers and by [
 
3
 
H]ryanodine binding assay. However, this mutation did not alter
the afﬁnity of [
 
3
 
H]ryanodine binding and the single-channel conductance. In addition, the E3987A mutant chan-
nel was activated by caffeine and ATP, was inhibited by Mg
 
2
 
 
 
, and was modiﬁed by ryanodine in a fashion similar
to that of the wild-type channel. Coexpression of the wild-type and mutant E3987A RyR2 proteins in HEK293 cells
produced individual single channels with intermediate sensitivities to activating Ca
 
2
 
 
 
. These results are consistent
with the view that glutamate 3987 is a major determinant of Ca
 
2
 
 
 
 sensitivity to activation of the mouse RyR2 chan-
nel, and that Ca
 
2
 
 
 
 sensing by RyR2 involves the cooperative action between ryanodine receptor monomers. The
results of this study also provide initial insights into the structural and functional properties of the mouse RyR2,
which should be useful for studying RyR2 function and regulation in genetically modiﬁed mouse models.
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INTRODUCTION
 
Excitation-contraction (E-C)* coupling in heart muscle
 
is believed to occur via a mechanism known as Ca
 
2
 
 
 
-
 
induced Ca
 
2
 
 
 
 release (CICR; Endo, 1977; Fabiato, 1985;
Ebashi, 1991). Upon depolarization of the transverse tu-
bular membrane, the voltage-dependent Ca
 
2
 
 
 
 channel
or the dihydropyridine receptor (DHPR) is activated,
resulting in a small inﬂux of Ca
 
2
 
 
 
. This Ca
 
2
 
 
 
 entry is
thought to trigger the opening of the Ca
 
2
 
 
 
 release chan-
nel (ryanodine receptor [RyR]), leading to a large Ca
 
2
 
 
 
release from the sarcoplasmic reticulum (SR) and sub-
sequent muscle contraction (Coronado et al., 1994;
Meissner, 1994; Ogawa, 1994; Sorrentino, 1995; Sutko
and Airey, 1996; Zucchi and Ronca-Testoni, 1997).
Thus, RyR acts like a Ca
 
2
 
 
 
 ampliﬁer, sensing and ampli-
fying the Ca
 
2
 
 
 
 signal from DHPR. To achieve efﬁcient
and stable Ca
 
2
 
 
 
 ampliﬁcation, the RyR Ca
 
2
 
 
 
 amplifying
system must possess a unique Ca
 
2
 
 
 
-sensing element that
is able to detect small local Ca
 
2
 
 
 
 signals from DHPR and
to avoid being further activated by the much larger out-
put signal from its own system, the SR Ca
 
2
 
 
 
 release. The
sensitivity or the threshold of RyR to Ca
 
2
 
 
 
 activation,
therefore, is an important parameter in determining
the gain and stability of E-C coupling (Cheng et al.,
1996; Cannell and Soeller, 1997; Stern et al., 1999). Al-
terations in the sensitivity of RyR to Ca
 
2
 
 
 
 activation have
been implicated in diseases including malignant hyper-
thermia and heart failure (Mickelson and Louis, 1996;
Loke and MacLennan, 1998; Marx et al., 2000).
 
Despite the central role of Ca
 
2
 
 
 
 activation of RyR in
CICR and in cardiac E-C coupling, the molecular mech-
anism of Ca
 
2
 
 
 
 sensing by RyR has been elusive. Three
RyR isoforms (RyR1, RyR2, and RyR3) have been identi-
ﬁed and cloned, and their responses to Ca
 
2
 
 
 
 have been
investigated (Coronado et al., 1994; Meissner, 1994;
Ogawa, 1994; Sorrentino, 1995; Sutko and Airey, 1996;
Zucchi and Ronca-Testoni, 1997). It has been shown
that, in muscle cells, RyR3 exhibits much lower sensitiv-
ity to activation by Ca
 
2
 
 
 
 than RyR1, and that RyR2 has
the highest sensitivity to Ca
 
2
 
 
 
 activation (Takeshima et
al., 1995; Yamazawa et al., 1996). On the other hand, sin-
gle-channel studies have demonstrated that, under the
same conditions, detergent-solubilized and sucrose gra-
dient–puriﬁed single recombinant RyR1 and RyR3 chan-
nels exhibit a similar threshold to Ca
 
2
 
 
 
 activation (Chen
et al., 1997a,b). Similar sensitivities to Ca
 
2
 
 
 
 activation of
the recombinant RyR1 and RyR2 expressed in HEK293
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cells also have been shown by using [
 
3
 
H]ryanodine bind-
ing assay (Du et al., 1998). Thus, these observations sug-
gest that although the sensitivity to Ca
 
2
 
 
 
 activation of dif-
ferent RyR isoforms may be modulated differently in
cells, the major determinant of their intrinsic Ca
 
2
 
 
 
 sensi-
tivities is most probably conserved.
 
Activation of RyR by Ca
 
2
 
 
 
 is believed to result from
binding of Ca
 
2
 
 
 
 ions to the high afﬁnity Ca
 
2
 
 
 
 binding
sites in the channel protein (Meissner et al., 1986,
1997). The locations of these high afﬁnity Ca
 
2
 
 
 
 activa-
tion sites have not been identiﬁed. Most mutations as-
sociated with malignant hyperthermia and central core
disease have been found in the NH
 
2
 
-terminal and cen-
tral region of the skeletal muscle RyR (RyR1; Mickelson
and Louis, 1996; Loke and MacLennan, 1998). Some of
these mutations have been shown to alter the sensitivity
to caffeine and Ca
 
2
 
 
 
 (Mickelson and Louis, 1996; Tong
et al., 1997; Loke and MacLennan, 1998). However, the
major determinant for Ca
 
2
 
 
 
 activation is most likely to
 
be located within the COOH-terminal 
 
 
 
1,000 amino
acid residues, rather than in the NH
 
2
 
-terminal region
of RyR, since a truncated RyR1 lacking 
 
 
 
4,000 residues
from the NH
 
2
 
 terminus retains Ca
 
2
 
 
 
 activation (Bhat et
al., 1997). Further deletion studies have also precluded
residues 4,274–4,535 as the site for Ca
 
2
 
 
 
 activation, as
deletion of this region led to an increase in sensitivity
of the channel to caffeine and Ca
 
2
 
 
 
 (Du et al., 2000).
Thus, the Ca
 
2
 
 
 
 activation sites most probably lie within
the NH
 
2
 
-terminal quarter or the COOH- terminal half
of the last 
 
 
 
1,000 residues of RyR.
 
Site-speciﬁc mutational studies have provided new
 
insights into the molecular determinant of Ca
 
2
 
 
 
 ac-
 
tivation (Chen et al., 1998). We have recently dem-
 
onstrated that a single substitution of alanine for
glutamate 3885 (E3885A), located in the putative
transmembrane segment M2 of RyR3, reduces the sen-
sitivity to Ca
 
2
 
 
 
 activation by 
 
 
 
10,000-fold. It should be
noted that the corresponding M2 sequence (Zorzato et
al., 1990) in RyR1 is located within the NH
 
2
 
 terminus of
the truncated RyR1 that maintains Ca
 
2
 
 
 
 activation
(Bhat et al., 1997). Coexpression of the wild-type and
E3885A mutant RyR3 proteins resulted in synthesis of
single channels with intermediate sensitivities to Ca
 
2
 
 
 
activation. These observations have led us to postulate
that the glutamates at position 3885 of each RyR3
monomer contribute to the formation of the RyR3
Ca
 
2
 
 
 
 sensor (Chen et al., 1998).
In line with the importance of this conserved
glutamate in channel function and regulation, muta-
tion of the corresponding glutamate 4032 to alanine
(E4032A) in RyR1 abolished caffeine response and
[
 
3
 
H]ryanodine binding (Du and MacLennan, 1998).
However, it is not known whether the E4032A mutation
alters the sensitivity of RyR1 to activating Ca
 
2
 
 
 
 and/or
directly affects high afﬁnity ryanodine binding. The ap-
parently different impact of this mutation on RyR1 as
compared with that on RyR3 raises a question of
whether the role of this conserved glutamate is isoform-
dependent. Therefore, it is important to determine
whether the corresponding glutamate in another ryano-
dine receptor isoform, RyR2, plays any roles in Ca
 
2
 
 
 
 ac-
tivation. In the present investigation, we examined the
role in Ca
 
2
 
 
 
 sensing of the corresponding glutamate
3987 in the mouse RyR2. We cloned and expressed the
wild-type and E3987A mutant RyR2 cDNA in HEK293
cells. Functional properties, in particular the Ca
 
2
 
 
 
 re-
sponse of both the wild-type and E3987A mutant RyR2
channels, were characterized by using single-channel re-
cordings in planar lipid bilayers and by [
 
3
 
H]ryanodine
binding assay. Our results show that mutation E3987A
markedly reduces the sensitivity of the mouse RyR2
channel to activating Ca
 
2
 
 
 
, supporting the view that this
conserved glutamate is a key determinant of the RyR2
Ca
 
2
 
 
 
 sensor. This study also reveals single-channel prop-
erties of the mouse cardiac ryanodine receptor.
 
MATERIALS AND METHODS
 
Materials
 
 Anti-RyR mAb 34C was obtained from Afﬁnity BioReagents Inc.
Brain phosphatidylserine was obtained from Avanti Polar Lipid.
Egg phosphatidylcholine was purchased from Sigma-Aldrich.
 
Synthetic 1,2-dioleoyl-
 
sn
 
-glycerol-3-phosphoethanolamine (DOPE)
and 1-palmitoyl-2-oleoyl-
 
sn
 
-glycero-3-phosphocholine (POPC) were
from Northern Lipids.
 
Cloning and Expression of the Mouse RyR2 cDNA and 
Construction of the Mutant Construct 
 
Cloning of the mouse RyR2 cDNA and expression of RyR in
HEK293 cells have been described previously (Chen et al.,
1997b; Zhao et al., 1999; see Fig. 1). Point mutation of glutamate
3987 into alanine (E3987A) in mouse RyR2 was performed by
the overlapping extension method (Ho et al., 1989) using PCR.
A SalI and a MluI restriction site were ﬁrst introduced into the
full-length mouse RyR2 cDNA at position 11816 and 12340, re-
spectively, without altering the amino acid sequence. This mouse
 
RyR2 cDNA (SalI
 
 
 
, MluI
 
 
 
) was then used as a template for PCR.
 
The “outer” two oligonucleotides used are as follows: forward,
 
5
 
 
 
-GAGCAGGGGCAGCGTAAC-3
 
 
 
 and reverse, 5
 
 
 
-GAAGGTCTG-
 
CAGACGCGTGTCATTG-3
 
 
 
. The oligonucleotides for the E3987A
mutation are as follows: forward, 5
 
 
 
-TGTCTATGTTAGCAGG-
TAATGTGGT-3
 
 
 
 and reverse, 5
 
 
 
-ACCACATTACCTGCTAACATA-
GACA-3
 
 
 
. The sequence of the PCR product was conﬁrmed by
DNA sequencing. The SalI–MluI fragment was removed from the
PCR product and was used to replace the corresponding wild-
type (wt) fragment in the full-length RyR2 cDNA in pBluescript,
which was subcloned subsequently into the expression plasmid
pCDNA3.
 
Preparation of Cell Lysate from Transfected HEK293 Cells 
and Heavy Sarcoplasmic Reticulum from Canine 
Heart Muscle 
 
HEK293 cells grown for 24–26 h after transfection using Ca
 
2
 
 
 
phosphate precipitation were washed three times with PBS (137 
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mM NaCl, 8 mM Na
 
2
 
HPO
 
4
 
, 1.5 mM KH2PO4, and 2.7 mM KCl)
plus 2.5 mM EDTA, and were harvested in the same solution by
centrifugation. Cells from 15 tissue culture dishes (100 mm in di-
ameter) were solubilized in 2.5 ml lysis buffer containing 25 mM
Tris, 50 mM HEPES, pH 7.4, 137 mM NaCl, 1% CHAPS, 0.6%
egg phosphatidylcholine, 2.5 mM DTT, and a protease inhibitor
mix (1 mM benzamidine, 2  g/ml leupeptin, 2  g /ml pepstatin
A, 2  g /ml aprotinin, and 0.5 mM PMSF) on ice for 1 h. Cell ly-
sate was obtained after removing the unsolubilized materials by
centrifugation in microcentrifuge at 4 C for 30 min. Heavy SR
was isolated from canine cardiac muscle according to the
method described previously (Chamberlain et al., 1983). 2 mg of
canine SR was solubilized in 2.5 ml lysis buffer plus a protease in-
hibitor mix, and unsolubilized materials were removed by cen-
trifugation in microcentrifuge.
Sucrose Density Gradient Puriﬁcation of Recombinant RyR2 
and Canine RyR2 Proteins
2.5 ml of cell lysate or solubilized canine cardiac SR membranes
(2 mg in 2.5 ml) was layered on top of a 10.5-ml (7.5–25%, wt/
wt) linear sucrose gradient containing 25 mM Tris, 50 mM
HEPES, pH 7.4, 0.3 M NaCl, 0.1 mM CaCl2, 0.3 mM EGTA, 0.25
mM PMSF, 4  g/ml leupeptin, 5 mM DTT, 0.3% CHAPS, and
0.16% synthetic phosphatidylcholine. The gradient was centri-
fuged at 29,000 rpm in Beckman SW-41 rotor at 4 C for 17 h.
Fractions of 0.7 ml each were collected. Peak fractions contain-
ing RyR proteins, as determined by immunoblotting, were
pooled, aliquoted, and stored at  80 C.
Single-channel Recordings
Recombinant wt and E3987A mutant RyR2 and canine RyR2 pro-
teins solubilized and puriﬁed by sucrose density gradient centrif-
ugation were used for single-channel recordings as described
previously (Chen et al., 1997b; Zhao et al., 1999) with some mod-
iﬁcations. Brain phosphatidylserine and synthetic DOPE, dis-
solved in chloroform, were combined, in a 1:5 ratio (wt/wt),
dried under nitrogen gas, and suspended in 30  l of n-decane at
a concentration of 15 mg of lipid /ml. Bilayers were formed
across a 250- m hole in a Delrin partition separating two cham-
bers. The trans chamber (600  l) was connected to the head
stage input of an Axopatch 200A ampliﬁer (Axon Instruments
Inc.). The cis chamber (1.2 ml) was held at virtual ground. A
symmetrical solution containing 250 mM KCl and 25 mM
HEPES, pH 7.4, was used for recordings. A 2–4- l aliquot of the
sucrose density gradient–puriﬁed recombinant wild-type or mu-
tant mouse RyR2 proteins or native canine cardiac ryanodine re-
ceptor was added to the cis chamber. Unless otherwise indicated,
spontaneous channel activity was always tested for sensitivity to
EGTA and/or Ca2 , thereby providing information about the
Ca2  sensitivity, orientation in the bilayer, and stability of the in-
corporated channel. All subsequent additions were made to that
chamber in which the addition of EGTA inhibited the activity of
the incorporated channel. This chamber presumably corre-
sponds to the cytoplasmic side of the Ca2  release channel. Re-
cordings were ﬁltered at 1,500 Hz using a low-pass Bessel ﬁlter
(Frequency Devices), digitized at 20 kHz. The data were analyzed
using pClamp 6.0.3 software (Axon Instruments Inc.). Free Ca2 
concentrations were calculated using the computer program of
Fabiato and Fabiato (1979).
[3H]Ryanodine Binding
 Equilibrium [3H]ryanodine binding to cell lysate was performed
as described previously (Du et al., 1998) with some modiﬁca-
tions. [3H]ryanodine binding was performed in a total volume of
300- l binding solution containing 30  l of cell lysate, 500 mM
KCl, 25 mM Tris, 50 mM HEPES, pH 7.4, 0.5 mM EGTA, 0.7 mM
CaCl2, 0.1–100 nM [3H]ryanodine, and the protease inhibitor
mix at 37 C for 2 h. The binding mix was diluted with 5 ml ice-
cold washing buffer containing 25 mM Tris, pH 8.0, and 250 mM
KCl, and was immediately ﬁltered through Whatman GF/B ﬁl-
ters presoaked with 1% polyethylenimine. The ﬁlters were
washed and the radioactivities associated with the ﬁlters were de-
termined by liquid scintillation counting. Nonspeciﬁc binding
was determined by measuring [3H]ryanodine binding in the
presence of 20  M unlabeled ryanodine. All binding assays were
done in duplicate.
Ca2  Release Measurements
Free cytosolic Ca2  concentration in transfected HEK293 cells
was measured using the ﬂuorescence Ca2  indicator dye ﬂuo-3-
AM as described previously (Chen et al., 1997b) with some modi-
ﬁcations. Cells grown for 18–20 h after transfection were washed
four times with PBS and incubated in KRH buffer (125 mM
NaCl, 5 mM KCl, 1.2 mM KH2PO4, 6 mM glucose, 1.2 mM MgCl2,
2 mM CaCl2, and 25 mM HEPES, pH 7.4) without MgCl2 and
Figure 1. Cloning and functional expression of the mouse RyR2
cDNA. (A) The strategy and outline for the cloning of cDNA en-
coding the mouse RyR2. Four overlapping clones (mCRR1-
mCRR4, solid boxes) covering the entire coding region of the
mouse RyR2 cDNA (open box) were obtained by screening a
mouse cardiac cDNA library using six short PCR fragments as
probes. (B) Caffeine-induced Ca2  release in HEK293 cells trans-
fected with 6  g wt RyR2 cDNA (mRyR2 (wt)) (B, panel a), 6  g
mutant (E3987A) cDNA (B, panel b), or 6  g control (pCDNA3)
DNA (B, panel c). Fluorescence intensity of ﬂuo-3 loaded HEK293
cells was monitored continuously before and after addition of 2
mM caffeine (arrows). Decreases in ﬂuorescence upon additions
of caffeine are due to ﬂuorescence quenching by caffeine. (C) Im-
munoblotting of sucrose density gradient fractions of wt or
E3987A mutant RyR2 proteins. An aliquot of 10  l each sucrose
gradient fraction was used for immunoblotting. The wt and mu-
tant RyR2 proteins were detected by using the anti-RyR mAb 34C.
The top (right) and bottom (left) of the gradient were labeled.36 Ca2  Sensing by the Cardiac RyR
CaCl2 at room temperature for 40 min and at 37 C for 40 min.
After being detached from culture dishes by pipeting, cells were
collected by centrifugation at 2,500 rpm for 2 min in a Beckman
TH-4 rotor. Cell pellets were washed twice with KRH buffer and
loaded with 10  M ﬂuo-3 in KRH buffer plus 0.1 mg/ml BSA and
250   M sulﬁnpyrazone at room temperature for 60 min, fol-
lowed by washing with KRH buffer three times and resuspended
in 150  l KRH buffer plus 0.1 mg/ml BSA and 250  M sulﬁn-
pyrazone. The ﬂuo-3–loaded cells were added to 2 ml (ﬁnal vol-
ume) KRH buffer in a cuvette. Fluorescence intensity of ﬂuo-3 at
530 nm was measured in an SLM-Aminco series 2 luminescence
spectrometer with 480 nm excitation at 25 C (SLM Instruments).
RESULTS
Cloning and Functional Expression of the Mouse Cardiac 
Ryanodine Receptor cDNA
Fig. 1 A outlines the strategy for the cloning of the
mouse cardiac ryanodine receptor (RyR2) cDNA. The
mouse RyR2 cDNA encodes a 565-kD protein composed
of 4,967 amino acids. The deduced amino acid se-
quence of the mouse RyR2 shares 97% identity with that
of the rabbit (Nakai et al., 1990; Otsu et al., 1990) and
human RyR2 (Tunwell et al., 1996). To investigate the
single-channel properties of the mouse RyR2 and the
role in Ca2  sensing of the conserved glutamate 3987,
we constructed full-length cDNAs encoding the wild-type
(wt) and glutamate 3987 to alanine mutant (E3987A)
and expressed the constructs in HEK293 cells. Caffeine-
induced Ca2  release was readily detected in HEK293
cells transfected with the full-length wt mouse RyR2
cDNA, but not in cells transfected with the E3987A mu-
tant RyR2 cDNA or vector (pCDNA3) DNA (n   5; Fig.
1 B). However, the E3987A mutant RyR2 protein was ex-
pressed in HEK293 cells and exhibited sedimentation
proﬁle similar to that of the wt (Fig. 1 C), suggesting
that the lack of caffeine response of the E3987A mutant
is unlikely to be due to defects in expression.
Mutation E3987A Altered the Ca2  Response of Single Mouse 
RyR2 Channels 
To further understand the defect in mutant E3987A, we
incorporated the wt and E3987A mutant proteins into
planar lipid bilayers and determined the open probabil-
ity (Po) of single channels at a wide range of Ca2  con-
centrations. As shown in Fig. 2 A, a single wt channel
was activated by Ca2  at  100 nM and was inactivated at
 10 mM. At Ca2  concentrations between  1 and 2,000
 M, the channel was maximally activated, resulting in a
bell-shaped Ca2  response curve (Fig. 2 C). Curve ﬁt-
ting of the wt Ca2  response using the Hill equation
yielded an EC50 of 0.26  M and a Hill coefﬁcient of 3.0
for activation by Ca2  (n   22) and an IC50 of 2.1 mM
and a Hill coefﬁcient of 1.3 for inactivation by Ca2 
(n   19). The extent of inactivation of single wt chan-
nels by high concentrations of Ca2  was found to vary
from channel to channel. Some channels were inacti-
vated, whereas the others remained highly active at high
Ca2  concentrations (Fig. 2 C). In contrast, the E3987A
mutant channels required several hundreds of micromo-
lar Ca2  for activation and hardly responded to increas-
ing Ca2  concentrations (Fig. 2 B). The maximum Po of
most E3987A mutant channels activated by a wide range
of Ca2  concentrations was  0.05 (Fig. 2 C). In addi-
tion, opening events of the E3987A mutant channels
were extremely brief. The mean open time of single
E3987A mutant channels is  10-fold shorter than that
of the wt channels (Fig. 2, A and B). It appears that
some opening events were too brief to be resolved com-
pletely under our recording conditions (Fig. 2 B). Thus,
the Po of the E3987A mutant channels activated by Ca2 
alone may have been under estimated. Nevertheless,
these data indicate that mutation E3987A severely im-
pairs the threshold, maximum extent, and kinetics of
Ca2  activation of the mouse RyR2.
Ligand Gating Properties of Single wt and E3987A Mutant 
RyR2 Channels
 We next examined the response of wt and E3987A mu-
tant RyR2 channels to various modulators. Consistent
with the results of [3H]ryanodine binding studies re-
ported previously (Zhao et al., 1999), single wt chan-
nels were activated by ATP and caffeine, and were in-
hibited by Mg2  ( n     5; Fig. 3 A). Similarly, single
E3987A mutant channels were also activated by ATP
and caffeine, and were inhibited by Mg2  (n   5; Fig. 3
B). It should be noted that the Ca2  concentrations in
the control conditions for wt ( 200 nM) and mutant
( 2 mM) channels differ considerably because of their
differences in Ca2  activation (Fig. 2). Hence, the ex-
tent of activation or inhibition by a ligand of the wt and
mutant channels may not be compared quantitatively.
It should also be noted that Mg2  could inhibit Ca2 -
activated wt or mutant E3987A channels in the absence
of ATP and caffeine (not shown). Both the wt and
E3987A mutant channels were modiﬁed in a similar
fashion by ryanodine, which shifted the channel into a
state with high Po and reduced conductance (Fig. 3 A,
panel e, and Fig. 3 B, panel f). The single-channel con-
ductance of the E3987A mutant channel is 793   2.8
pS (n   4), similar to that of the wt channels ( 800
pS). Thus, the E3987A mutation does not change the
single-channel conductance and does not cause gross
alterations in channel function.
Mutant E3987A Retained High Afﬁnity 
[3H]Ryanodine Binding
 Different from mutant E3987A in RyR2, the corre-
sponding mutant E4032A in RyR1 showed no response
to either caffeine or ryanodine and lacked high afﬁnity
[3H]ryanodine binding. It has been suggested that the
E4032A mutation may affect ryanodine binding di-37 Li and Chen
Figure 2. Ca2  response of
single wt and E3987A mutant
RyR2 channels. Single-chan-
nel activities of the wt
(mRyR2(wt)) (A) and the
E3987A mutant (B) were re-
corded in a symmetrical re-
cording solution containing
250 mM KCl, 25 mM Hepes,
pH 7.4, and varying concen-
trations of cytoplasmic free
Ca2 . The orientation of each
single channel detected in the
bilayer was determined at the
beginning of each experiment
by addition of an aliquot of
EGTA solution to either the
cis or the trans chamber. The
trans chamber was connected
to the input of the headstage
ampliﬁer and the cis chamber
was held at virtual ground. Sin-
gle-channel activities shown in
A and B were inhibited by ad-
dition of 0.1 mM EGTA to the
cis chamber, indicating that
the cytoplasmic side of the in-
corporated channel was facing
the cis chamber. All subse-
quent additions were made to
the cytoplasmic side of the channel (cis chamber). The relationships between Po and Ca2  concentrations of single wt (solid circles) and
E3987A mutant (open circles) channels are shown in C. Data points shown are individual Po measurements from 22 single wt channels and
16 single E3987A mutant channels. Curve shown represents ﬁt of data from single wt channels using the Hill equation. Data points at Ca2 
concentrations  1 mM from three single wt channels that did not show signiﬁcant Ca2 -dependent inactivation were not included in the ﬁt-
ting for Ca2  inactivation. The parameters of the ﬁtting are indicated in the text. Note that the sensitivities of single wt channels to activation
by Ca2  are similar, with a threshold for activation  100 nM, whereas the sensitivities to inactivation by Ca2  vary signiﬁcantly among single wt
channels. The threshold for activation of single E3987A mutant channels by Ca2  is  0.2 mM. The maximum Po of the Ca2 -activated
E3987A mutant channels ranges from 0.01 to 13%. The open probability (Po), arithmetic mean open time (To), and the arithmetic mean
closed time (Tc) at each Ca2  level are indicated on the top of each panel. A short line to the right of each current trace indicates the base
line. The holding potential for both the wt and E3987A mutant channels was  20 mV.
Figure 3. Ligand gating
properties of single wt (A)
and E3987A mutant (B) RyR2
channels. Single-channel re-
cordings were performed as
described in the legend to
Fig. 2. (A) Control a was per-
formed in the presence of
171 nM cytoplasmic free
Ca2 . Subsequent additions
of ATP, caffeine, Mg2 , and
ryanodine were made to the
cytoplasmic side of the same
channel. (B) The concentra-
tion of free Ca2  in control a
is 1.7 mM, and the recording
solution in control d con-
tains 1.7 mM Ca2 , 0.5 mM
EGTA, 2 mM ATP, and 4 mM
caffeine. Current recordings
in a–c are from the same
channel, whereas those in d–f
are from a different channel.
Base lines are indicated. The
holding potential was  20
mV for all recordings shown.38 Ca2  Sensing by the Cardiac RyR
rectly (Du and MacLennan, 1998). The characteristic
functional response to ryanodine of single E3987A mu-
tant RyR2 channel shown in Fig. 3 indicates that the
functional high afﬁnity ryanodine binding site is re-
tained in the mutant channel. However, it is possible
that the E3987A mutation could affect the properties
of ryanodine binding in addition to Ca2  activation. To
test this possibility, we determined the equilibrium dis-
sociation constant of [3H]ryanodine binding to mutant
E3987A in the presence of 1 mM Ca2  (Fig. 4). Scat-
chard analysis showed that the E3987A mutant RyR2
exhibited high afﬁnity [3H]ryanodine binding with a
Kd of 2.1   0.39 nM and a Bmax of 0.76   0.15 pmol/mg
(n   5), similar to the Kd of 2.3   0.63 nM and Bmax of
1.24   0.26 pmol/mg (n   4) of the wt RyR2. High af-
ﬁnity [3H]ryanodine binding to the corresponding mu-
tant E3885A in RyR3 was also detected (data not
shown). Therefore, mutation of this conserved glu-
tamate does not alter the afﬁnity of [3H]ryanodine
binding to RyR2.
Mutation E3987A Markedly Reduced the Sensitivity of Mouse 
RyR2 Channels to Activating Ca2 
 As seen in Fig. 3 B, single E3987A mutant channels
could be fully activated by Ca2  in the presence of ATP
Figure 4. Mutation E3987A does not alter the afﬁnity of [3H]ry-
anodine binding to RyR2. [3H]ryanodine binding to cell lysate
prepared from HEK293 cells transfected with wt or mutant
E3987A cDNA was performed in the presence of 25 mM Tris, 50
mM HEPES, pH 7.4, 500 mM KCl, CaCl2 (0.2 mM for wt and 1.0
mM for mutant E3987A), 0.1–30 nM [3H]ryanodine, and various
protease inhibitors at 37 C for 2 h. Data shown are from a repre-
sentative experiment, which has been repeated three to four
times. Inset shows a Scatchard plot.
Figure 5. Mutation E3987A
reduced dramatically the sen-
sitivity of single mouse RyR2
channel to Ca2  activation.
The Ca2  responses of single
wt (A) and E3987A mutant (B
and C) channels were deter-
mined in the presence of 2
mM ATP and 4 mM caffeine.
Other conditions for record-
ings were the same as de-
scribed in Fig. 2. According to
their maximum Po, single
E3987A mutant channels
could be divided into two
groups with high (B) and low
Po (C). The Po-pCa relation-
ships of the wt and E3987A
mutant channels are shown
in D. Data points shown are
individual Po measurements
from ﬁve single wt channels
(solid circles), ﬁve E3987A
mutant channels with high Po
(open triangles), and ﬁve
E3987A mutant channels with
low Po (solid triangles). Lines
represent curve ﬁts using the
Hill equation. The yielded pa-
rameters of ﬁtting are indi-
cated in the text. The holding
potential for all recordings
shown was  20 mV. Base lines
are indicated.39 Li and Chen
and caffeine. This property allows us to quantify the rel-
ative Ca2  sensitivity of the E3987A mutant channels at
the single-channel level. As shown in Fig. 5 A, in the
presence of 2 mM ATP and 4 mM caffeine, a single wt
channel was activated by  50 nM Ca2  and reached
maximum activation at  300 nM Ca2 . The Ca2  re-
sponse of single wt channels under these conditions
could be described by an EC50 of 93 nM and a Hill coef-
ﬁcient of 3.1 (n   5; Fig. 5 D). On the other hand,
under the same conditions, single mutant E3987A
channels were activated by submicromolar Ca2  and
reached maximum activation at  500  M (Fig. 5, B
and C). The difference in the extent of maximum acti-
vation was observed among single E3987A mutant
channels. Some mutant channels could be fully acti-
vated, whereas others showed maximum activation of
 50% (Fig. 5, B–D). This discrepancy is most likely at-
tributable to different extents of Ca2  inactivation, as
seen among single wt channels (Fig. 2 C). The Ca2  re-
sponses of the high and low Po E3987A mutant chan-
nels were analyzed by using the Hill equation. These
analyses yielded an EC50 of 109  M and a Hill coefﬁ-
cient of 1.1 for Ca2  activation of the high Po E3987A
mutant channels (n   5), and an EC50 of 246  M and a
Hill coefﬁcient of 1.63 for Ca2  activation of the low Po
mutant channels (n   5). Hence, single E3987A mu-
tant channels exhibited  1,000–3,000-fold reduction
in Ca2  sensitivity to activation as compared with single
wt RyR2 channels. We have previously shown that the
corresponding mutation E3885A in the RyR3 isoform
reduced the Ca2  sensitivity of single RyR3 channels to
activation in lipid bilayers by  10,000-fold (Chen et al.,
1998), which is 3–10 times more severe in reducing the
Ca2  sensitivity than does the E3987A mutation in the
RyR2 isoform. This observed variance might reﬂect dif-
ferences in the exact composition of the Ca2  sensor or
differences in the Ca2  activation pathway between the
RyR2 and RyR3 isoform.
Marked reduction in the sensitivity of the E3987A mu-
tant channel to Ca2  activation could be also demon-
strated in the absence of ATP and caffeine by using
[3H]ryanodine binding assay. Although mutant E3987A
exhibited a binding afﬁnity and maximum binding ca-
pacity similar to those of the wt (Fig. 4), they differ con-
siderably in the Ca2  dependence of [3H]ryanodine
binding. [3H]ryanodine binding to wt proteins was acti-
vated by Ca2  with an EC50 of 0.22   0.03  M and a Hill
coefﬁcient of 2.6   0.34 (n   6), whereas activation by
Ca2  of [3H]ryanodine binding to mutant E3987A pro-
teins could be described by an EC50 of 59   14  M and a
Hill coefﬁcient of 1.3   0.3 (n   6; Fig. 6). Thus, the
E3987A mutation resulted in  270-fold reduction in
Ca2  sensitivity to activation of [3H]ryanodine binding.
This estimated reduction in Ca2  sensitivity differs by
 4–10-fold from that estimated by single-channel mea-
surements. The Ca2  sensitivity of the wt channels esti-
mated by single-channel measurements (0.26  M) is
similar to that (0.22  M) estimated by [3H]ryanodine
binding analysis (Figs. 2 and 6). On the other hand, the
relative Ca2  sensitivity to activation of single E3987A
mutant channels measured in lipid bilayers may have
been underestimated due to the inﬂuence of Ca2 -
dependent inhibition (Fig. 5 D). As a result, the differ-
ences in Ca2  sensitivity between single wt and E3987A
mutant channels measured in lipid bilayers may have
been overestimated. It is of interest to note that signiﬁ-
cant Ca2 -dependent inhibition of [3H]ryanodine bind-
ing was not detected at Ca2  concentrations as high as
1 M (Fig. 6). The lack of Ca2 -dependent inhibition of
[3H]ryanodine binding to rabbit RyR2 proteins also has
been reported previously (Du and MacLennan, 1999).
With little inﬂuence by Ca2 -dependent inhibition,
[3H]ryanodine binding assay may provide more accurate
estimates of the sensitivity of the mutant channels to acti-
vation by Ca2 , especially at high Ca2  concentrations.
Coexpression of wt and E3987A Mutant RyR2 
Proteins Produced Single Channels with 
Intermediate Ca2  Sensitivities
To investigate the role of subunit interaction in Ca2 
activation of the tetrameric RyR channel, we coex-
pressed the wt and E3987A mutant proteins in HEK293
cells and determined the Ca2  response of each single
channel detected in lipid bilayers (Fig. 7). A total of
19 single channels were observed and characterized.
Based on their responses to Ca2 , these single channels
could be divided into ﬁve groups. Group I (6/19) ex-
hibited a Ca2  response similar to that of the wt, with
an EC50 of 0.40  M and a Hill coefﬁcient of 2.8 for acti-
Figure 6. Ca2  dependence of [3H]ryanodine binding to wt and
mutant E3987A proteins [3H]ryanodine binding to cell lysate pre-
pared from HEK293 cells transfected with wt or mutant E3987A
cDNA was performed at various concentrations of Ca2 , as de-
scribed in materials and methods. The concentration of [3H]ry-
anodine used was 10 nM. Data shown are individual measure-
ments from six separate binding experiments.40 Ca2  Sensing by the Cardiac RyR
vation by Ca2  (Fig. 7 D, solid circles). This group of
single channels most probably corresponds to the wt
homotetramer. On the other hand, single channels in
group II (2/19) were hardly activated by Ca2 , resem-
bling the E3987A mutant homotetramer (Fig. 7 D,
solid triangles). Group III (medium Po; 4/19) dis-
played a Ca2  response clearly different from that of
the wt homotetramer and E3987A mutant homotet-
ramer, exhibiting an EC50 of 85  M and a Hill coefﬁ-
cient of 2.0 for activation by Ca2  (Fig. 7, B and D, solid
squares). Since the E3987A mutant protein forms a
functional channel, presumably a homotetramer, it is
most likely that the E3987A mutant protein is capable
of forming a heterotetrameric channel with the wt pro-
tein. If so, group III single channels most probably rep-
resents hybrid channels formed by the wt and E3987A
mutant subunits. The Ca2  response of group IV (high
Po) single channels (5/19; open circles) was found to
be in between or similar to those of group I (wt ho-
motetramer) and group III (presumably wt/mutant hy-
brid; Fig. 7, A and D). Group V (low Po; 2/19) showed
Ca2  response in between or similar to those of the
group III (presumably wt/mutant hybrid) and group II
(E3987A mutant homotetramer) (Fig. 7, C and D,
open squares). Because of the overlap in Ca2  response
with the wt homotetramer or with the mutant homotet-
ramer, we are not certain that single channels in groups
IV and V are all wt/mutant hybrid channels. Neverthe-
less, it is clear from Fig. 7 D that coexpression of the wt
and E3987A mutant proteins produced single channels
displaying sensitivities to activating Ca2  in between
those of the wt and E3987A mutant RyR2 channels.
These results also indicate that the sensitivity to activa-
tion of the RyR2 Ca2  sensor may depend on the coop-
erative interaction among RyR monomers.
Single Mouse RyR2 Channels Exhibited Ca2  Response 
Similar to that of Single Canine RyR2 Channels 
The mouse heart is quite different from that of other
mammalian species. The most distinctive feature of the
mouse heart is its fast heart rate (500–600 beats per
minute; Hamilton and Ianuzzo, 1991). It has been sug-
gested that the contractile and Ca2  regulating systems
Figure 7. Ca2  responses of
single channels produced
by coexpression of the wt
and E3987A mutant RyR2
proteins in HEK293 cells.
HEK293 cells were trans-
fected with an equal amount
(6  g) of wt and E3987A mu-
tant RyR2 cDNA. The Ca2 
responses of single hybrid
channels with high Po (A),
medium Po (B), and low Po
(C) were determined as de-
scribed in the legend to Fig.
2. Single-channel activities
shown in A and B were inhib-
ited by addition of 0.1 mM
EGTA to the cis chamber, in-
dicating that the cytoplasmic
side of the incorporated
channel was facing the cis
chamber. On the other hand,
single-channel activities
shown in C were inhibited by
addition of 0.1 mM EGTA to
the trans chamber, indicating
that the cytoplasmic side of
the incorporated channel was
facing the trans chamber. To
measure currents in the same
direction, from the luminal to
the cytoplasmic side of the channel, a  20-mV holding potential was applied in A and B and  20 mV in C. The Po-pCa relationships of
single hybrid channels are shown in D. Data points represent individual measurements. According to their Ca2  sensitivities to activation,
single hybrid channels could be divided into at least ﬁve groups (I–V). Group I (solid circles) and group II (solid triangles) displayed Ca2 
sensitivity to activation similar to that of the wt and E3987A mutant channel, respectively. Group III (solid squares), group IV (open cir-
cles), and group V (open squares) showed sensitivities to Ca2  activation in between those of the wt and E3987A mutant channels. These
different Ca2  sensitivities most probably resulted from hybrid channels with different compositions of wt and E3987A mutant subunits.
Note that two single channels are present in recordings shown in C and Po indicates the average open probability.41 Li and Chen
in the mouse heart must possess unique properties to ac-
commodate such a high frequency operation (Hamilton
and Ianuzzo, 1991). For example, mouse heart muscle
contains a large amount of SR, which may help to speed
up muscle relaxation (Forbes et al., 1985). In this con-
text, it would be of interest to examine whether the Ca2 
response of the mouse RyR2 channel differs from that of
RyR2 from other mammalian species, such as dog which
has much slower heart rate (Hamilton and Ianuzzo,
1991). Fig. 8 shows the Ca2  response of single canine
RyR2 channels and comparison with that of single
mouse RyR2 channels. Under the same conditions as for
mouse RyR2, single canine RyR2 channels were acti-
vated by Ca2  with an EC50 of 0.24  M and a Hill coefﬁ-
cient of 2.8, and were inactivated by Ca2  with an IC50 of
4.8 mM and a Hill coefﬁcient of 1.3. These parameters
are very similar to those observed with single mouse
RyR2 channels (Figs. 2 and 8 B). Thus, the intrinsic Ca2 
dependence of single mouse and canine RyR2 channels
in lipid bilayers appears to be similar.
DISCUSSION
The Role of the Conserved Glutamate in Ca2  Activation of 
Different RyR Isoforms
In earlier studies, we have provided evidence that
glutamate 3885 is a major determinant of the sensitivity
of RyR3 to activation by Ca2  (Chen et al., 1998). Con-
sidering the highly conserved nature of the glutamate
and its ﬂanking residues in the M2 sequence, one
would expect that the corresponding glutamate in
other RyR isoforms would play a similar role in Ca2 
sensing. In a recent study, the corresponding glutamate
4032 in RyR1 was mutated into alanine (E4032A). Un-
like the E3885A mutant RyR3, the E4032A mutant
RyR1 expressed in HEK293 cells showed neither caf-
feine response nor [3H]ryanodine binding, even under
the conditions that would fully activate the E3885A mu-
tant RyR3 channel (Du and MacLennan, 1998). Al-
though these observations support the view that glu-
tamate 4032 is essential for RyR1 channel function
and regulation, the role of this glutamate in Ca2  acti-
vation of RyR1 is unclear. These observations also raise
an important question of whether this conserved glu-
tamate is involved in Ca2  activation of RyR isoforms
other than RyR3.
In view of the essential role of Ca2  activation of
RyR2 in CICR and in E-C coupling, we set out to investi-
gate the molecular basis of activation of RyR2 by Ca2 
and to determine whether the Ca2 -sensing role of this
conserved glutamate is maintained in the RyR2 iso-
form. To this end, we have cloned the cDNA encoding
the mouse RyR2 and made the corresponding muta-
Figure 8. Single mouse and
canine RyR2 channels share
similar Ca2  response. Single-
channel activities of the ca-
nine RyR2 were recorded as
described in materials and
methods and in the legend
to Fig. 2. Single-channel activ-
ities shown in A were inhib-
ited by the addition of 0.1
mM EGTA to the cis cham-
ber, indicating that the cyto-
plasmic side of the incorpo-
rated channels was facing the
cis chamber. All subsequent
additions were made to the
cytoplasmic side of the chan-
nel (cis chamber). Current
traces (21 nM–0.27  M)
shown on the left and those
(2–18 mM) shown on the
right were from separate
channels. The relationships
between Po and Ca2  concen-
trations of single canine
(open circles, solid line) and
mouse (dashed line, from
Fig. 2) RyR2 channels are
shown in B. Data points shown are individual Po measurements from nine single canine RyR2 channels. The holding potential was  20
mV for Ca2  concentrations at 21 nM, 64 nM, 126 nM, 190 nM, 0.27  M, and 2 mM, and  40 mV for Ca2  concentrations at 5.5 and 18
mM. The open probability (Po), arithmetic mean open time (To) and the arithmetic mean closed time (Tc) at each Ca2  level are indi-
cated on the top of each panel. A short line to the right of each current trace indicates the base line.42 Ca2  Sensing by the Cardiac RyR
tion E3987A. Single-channel properties of the wt and
E3987A mutant RyR2 were assessed and compared.
Our results demonstrate that the E3987A mutant RyR2
channels exhibit marked reduction in the sensitivity to
activating Ca2 , while retaining similar single-channel
conductance, high afﬁnity [3H]ryanodine binding, and
responses to ATP, caffeine, Mg2 , and ryanodine. These
properties of the E3987A mutant RyR2 are very similar
to those of the E3885A mutant RyR3, indicating that
the speciﬁc role of glutamate 3987 in Ca2  sensing is
conserved in the RyR2 isoform.
The reasons for the lack of activity of the E4032A mu-
tant RyR1 are not known. One possible explanation for
the observed discrepancy between the E4032A mutant
RyR1 and E3987A mutant RyR2 or E3885A mutant
RyR3 may lie, in part, in different sensitivities of these
mutant channels to inactivation by high Ca2  concen-
trations. RyR1 is known to be 10–20 times more sensi-
tive to inactivation by Ca2  than RyR2 or RyR3 (Chen
et al., 1997b; Laver et al., 1995). Robust Ca2  inactiva-
tion in RyR1 may prevent the E4032A mutant channel
from being considerably activated at high Ca2  concen-
trations even in the presence of channel activators such
as ATP and caffeine.
As to the E3987A mutant RyR2, Ca2  activation is par-
tially overlapped with Ca2  inactivation due to the
much lower sensitivity of RyR2 to inactivating Ca2 . Re-
sidual activity of the E3987A mutant channel could be
detected at submillimolar Ca2 , although its Ca2  re-
sponse was signiﬁcantly suppressed at higher Ca2  con-
centrations (Fig. 2, B and C). This suppression could
be alleviated by the addition of ATP and caffeine (Fig.
5). ATP and caffeine are known to be able to increase
the sensitivity to Ca2  activation and decrease the sensi-
tivity to Ca2  inactivation of the channel (Meissner et
al., 1997). These effects of ATP and caffeine would ef-
fectively reduce the overlap between Ca2  activation
and Ca2  inactivation of the E3987A mutant channel so
much that the mutant channel could now be activated
considerably by Ca2  before Ca2  inactivation could oc-
cur. Conversely, because of the robust Ca2  inactivation
in RyR1, signiﬁcant overlap between Ca2  activation
and Ca2  inactivation may still exist in the E4032A mu-
tant RyR1 channel in the presence of ATP and caffeine.
The sensitivity to Ca2  inactivation differs also among
single recombinant mouse RyR2 channels (Fig. 2 C).
Some single recombinant mouse RyR2 channels dis-
played no signiﬁcant level of Ca2  inactivation. Hetero-
geneity in Ca2  inactivation of single native rabbit RyR2
channels has also been observed (Copello et al., 1997).
The molecular basis for the heterogeneity is not
known. Calmodulin has been shown recently to medi-
ate Ca2 -dependent inactivation of the L-type Ca2 
channel, the inositol 1,4,5-trisphosphate receptor, and
the RyR1 isoform (Tripathy et al., 1995; Lee et al., 1999;
Michikawa et al., 1999; Peterson et al., 1999; Qin et al.,
1999; Zuhlke et al., 1999; Rodney et al., 2000). How-
ever, the signiﬁcance of CaM in Ca2 -dependent inacti-
vation of RyR2 remains to be determined.
Possible Mechanisms of Ca2  Sensing by RyR
It is clear from the results of our present and previous
studies that the absolutely conserved glutamate located
in the putative transmembrane sequence M2 is a key
residue in determining the sensitivity of RyR to activa-
tion by Ca2 . However, the molecular basis of how this
glutamate is involved in Ca2  sensing remains to be un-
derstood. One possibility is that each RyR subunit has
one Ca2  sensor and that the conserved glutamate con-
tributes to the formation of the Ca2  sensor in each
subunit. Mutation of this glutamate would decrease the
sensitivity of each sensor to Ca2  activation and proba-
bly alter the cooperativity between sensors, thus, reduc-
ing the overall sensitivity and cooperativity of the tet-
rameric RyR channel to Ca2  activation. This multi-sen-
sor model is analogous to that proposed for Ca2 
activation of Ca2 -activated potassium channels in
which activation of all four Ca2  sensors is necessary for
channel opening and the steeply cooperative channel
gating would arise from the cooperative interaction be-
tween sensors (Fanger et al., 1999; Keen et al., 1999)
Alternatively, each subunit may contribute partially
to the formation of a single Ca2  sensor in the tet-
rameric RyR channel, and the conserved glutamates of
each subunit may be located in close proximity and act
cooperatively to form a major part of the Ca2  sensor.
The sensor could be composed of two or more cooper-
ative Ca2  binding sites. Mutation of this glutamate
would affect both the sensitivity and cooperativity of
the sensor to activating Ca2 . This single-sensor model
is reminiscent of the Ca2  binding sites in the SR Ca2 
pump in which amino acid residues from four trans-
membrane segments contribute to the formation of
two Ca2  binding sites (MacLennan et al., 1998; To-
yoshima et al., 2000). Both the multi- and single-sensor
models are, apparently, compatible with the observed
results. Further studies are required for distinguishing
these models. For example, localization of the Ca2 
sensor(s) in the 3-D architecture of RyR would provide
some essential clues to the molecular mechanisms of
Ca2  sensing.
Channel Properties of the Mouse RyR2
Most information on RyR2 channel properties has pri-
marily come from studies using sheep, canine, or rabbit
hearts. Little is known about the channel properties of
RyR2 from the mouse heart. This is due, in part, to the
limited amount of mouse RyR2 proteins that could be
isolated and used for either biochemical or electro-43 Li and Chen
physiological analyses. In the present study, we were
able to express the mouse RyR2 cDNA in HEK293 cells
and functionally characterize the recombinant mouse
RyR2 protein at the single-channel level. We show that
recombinant mouse RyR2 channels can be activated by
ATP and caffeine, inhibited by Mg2 , and modiﬁed by
ryanodine. The Ca2  response of the mouse RyR2
channels is biphasic, being activated by Ca2  at low con-
centrations and inhibited by Ca2  at high concentra-
tions, similar to that of the canine RyR2 channels. Fur-
ther mutational studies should lead to a better under-
standing of the structure and function relationships of
the mouse RyR2 channel. This kind of knowledge
should be useful for manipulating speciﬁc properties
of the mouse RyR2 channel such as Ca2  sensing and
ion conduction and assessing the physiological signiﬁ-
cance of these properties in cardiac function via ge-
netic engineering of the mouse RyR2 gene.
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